Completed PHASE2 INTERVENTIONAL 2-arm NCT00967616

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

Sponsor: Daiichi Sankyo

Conditions Colorectal Cancer Neoplasms, Colorectal

Interventions CS7017 irinotecan, leucovorin, and 5-fluorouracil (5-FU) (FOLFIRI)

Updated 10 times since 2017 Last updated: Apr 22, 2020 Started: Sep 30, 2009 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00967616, this PHASE2 trial focuses on Colorectal Cancer and Neoplasms, Colorectal and remains completed. Sponsored by Daiichi Sankyo, it has been updated 10 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Mar 2024 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Mar 2024 [monthly]

Completed PHASE2

▶ Show 5 earlier versions

Jun 2020 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Jun 2020 [monthly]

Completed PHASE2
Sep 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Sep 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daiichi Sankyo

Data source: Daiichi Sankyo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Bethesda, United States , Beverly Hills, United States , Buenos Aires, Argentina , Callao, Peru , Canton, United States , Fullerton, United States , Lima, Peru , Porto Alegre, Brazil , Rio de Janeiro, Brazil and 5 more locations